Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines.
Amgen s battle with Sanofi and Regeneron at the Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape US patent law and competition among companies that make antibody medicines.
Nokia s huge licensing margins; US patent suits up; Apple in China IP buying spree; AI patent first in South Africa; Tech innovators diversity pledge; plus much more iam-media.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iam-media.com Daily Mail and Mail on Sunday newspapers.
Why Register with Mondaq
Free, unlimited access to more than half a million articles (one-article limit removed) from the diverse perspectives of 5,000 leading law, accountancy and advisory firms
Articles tailored to your interests and optional alerts about important changes
Receive priority invitations to relevant webinars and events
You’ll only need to do it once, and readership information is just for authors and is never sold to third parties.
Your Organisation
We need this to enable us to match you with other users from the same organisation, it is also part of the information that we share to our content providers ( Contributors ) who contribute Content for free for your use.